Healthcare provider profile · identity verified

Michael Dean Marlow, DO

Family Practice · THE WOODLANDS, TX · NPI 1417991910

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	341	98
Levothyroxine Sodium	Levothyroxine Sodium	249	77
Rosuvastatin Calcium	Rosuvastatin Calcium	206	62
Lisinopril	Lisinopril	191	58
Amlodipine Besylate	Amlodipine Besylate	178	56
Tamsulosin Hcl	Tamsulosin Hcl	133	47
Metformin Hcl	Metformin Hcl	131	31
Prednisone	Prednisone	120	91
Gabapentin	Gabapentin	116	30
Losartan Potassium	Losartan Potassium	113	32
Metoprolol Succinate	Metoprolol Succinate	112	25
Fluticasone Propionate	Fluticasone Propionate	111	43
Pantoprazole Sodium	Pantoprazole Sodium	107	29
Alprazolam	Alprazolam	91	20
Hydrochlorothiazide	Hydrochlorothiazide	90	27
Mounjaro	Tirzepatide	88	15
Glipizide	Glipizide	82	20
Venlafaxine Hcl Er	Venlafaxine Hcl	82	16
Omeprazole	Omeprazole	80	31
Valsartan	Valsartan	79	25
Tramadol Hcl	Tramadol Hcl	76	18
Ozempic	Semaglutide	71	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	70	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	34
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	67	54
Meloxicam	Meloxicam	65	22
Carvedilol	Carvedilol	61	19
Synthroid	Levothyroxine Sodium	60	17
Zolpidem Tartrate	Zolpidem Tartrate	59	17
Duloxetine Hcl	Duloxetine Hcl	56	18
Jardiance	Empagliflozin	53	11
Pioglitazone Hcl	Pioglitazone Hcl	53	15
Clonazepam	Clonazepam	51	14
Simvastatin	Simvastatin	51	16
Metoprolol Tartrate	Metoprolol Tartrate	49	13
Montelukast Sodium	Montelukast Sodium	48	13
Albuterol Sulfate Hfa	Albuterol Sulfate	45	16
Trazodone Hcl	Trazodone Hcl	44	13
Citalopram Hbr	Citalopram Hydrobromide	41	13
Azelastine Hcl	Azelastine Hcl	39	28
Propranolol Hcl	Propranolol Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Cephalexin	Cephalexin	35	32
Metformin Hcl Er	Metformin Hcl	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Cefdinir	Cefdinir	33	24
Celecoxib	Celecoxib	33	11
Diazepam	Diazepam	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Cefuroxime	Cefuroxime Axetil	32	23
Eliquis	Apixaban	32	suppressed
Liothyronine Sodium	Liothyronine Sodium	32	suppressed
Sertraline Hcl	Sertraline Hcl	31	suppressed
Allopurinol	Allopurinol	30	11
Fluconazole	Fluconazole	30	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Valacyclovir	Valacyclovir Hcl	28	14
Azithromycin	Azithromycin	27	23
Ondansetron Hcl	Ondansetron Hcl	27	17
Alendronate Sodium	Alendronate Sodium	25	11
Methylprednisolone	Methylprednisolone	25	21
Bupropion Xl	Bupropion Hcl	24	suppressed
Famotidine	Famotidine	24	12
Lorazepam	Lorazepam	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Potassium Chloride	Potassium Chloride	23	11
Primidone	Primidone	23	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Atenolol	Atenolol	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol (Twice Weekly)	Estradiol	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Progesterone	Progesterone, Micronized	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Temazepam	Temazepam	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Baclofen	Baclofen	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Furosemide	Furosemide	15	suppressed
Levofloxacin	Levofloxacin	15	15
Metronidazole	Metronidazole	15	suppressed
Naproxen	Naproxen	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Finasteride	Finasteride	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Ramipril	Ramipril	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Estradiol	Estradiol	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Methimazole	Methimazole	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error